$135.99
$0.00 (0.00%)
End-of-day quote: 04/26/2024
NasdaqGS:NBIX
Neurocrine Biosciences Annual Report
| Year | Year | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Rev. | Revenue |
|
$1.89B | $1.49B | $1.13B | $1.05B | $788.09M | $451.24M | $161.63M | $15.00M | $19.77M | $0.00M | $2.92M | $53.14M | $77.41M | $33.50M | $2.95M | $3.98M | $1.22M | $39.23M | $123.89M | $85.18M | |
| GM % | Gross Margin % |
|
67.96% | 67.29% | 69.79% | 72.74% | 73.67% | 64.40% | 42.41% | -139.33% | -70.97% | 0.00% | 0.00% | 78.17% | 89.02% | 7.01% | 0.00% | 0.00% | 0.00% | -141.83% | 13.93% | -35.09% | |
| OM | Operating Margin |
|
20.92% | 16.73% | 18.33% | 31.31% | 28.75% | 9.23% | -62.71% | 0.00% | 0.00% | 0.00% | 0.00% | 4.78% | 43.93% | -32.60% | 0.00% | 0.00% | 0.00% | -264.61% | -20.24% | -61.44% | |
| EPS | Earnings Per Share |
|
$0.00 | $4.09 | $3.47 | $1.90 | $4.11 | $0.39 | $0.22 | $-1.62 | $-1.63 | $-1.05 | $-0.81 | $-0.69 | $0.08 | $0.67 | $-0.12 | $-1.24 | $-2.30 | $-2.98 | $-2.84 | $-0.60 | $-1.26 |
| Div. | Dividends |
|
$0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | |
| PR % | Payout Ratio % |
|
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -0.00% | 0 | 0 | 0 | -0.00% | 0.00% | 0 | 0 | 0 | 0 | -0.00% | -0.00% | -0.00% | -0.00% | |
| Sha. | Shares |
|
98.7m | 96.5m | 94.9m | 93.5m | 92.27m | 90.8m | 88.79m | 86.88m | 86.26m | 76.47m | 67.35m | 66.45m | 55.26m | 54.88m | 43.99m | 38.6m | 38.27m | 37.91m | 37.13m | 36.53m | |
| OCF | Operating Cash Flow |
|
$389.90M | $339.40M | $256.50M | $228.50M | $152.05M | $101.36M | $-94.33M | $-106.18M | $-38.00M | $-47.14M | $-29.61M | $-35.29M | $-0.70M | $49.94M | $-53.10M | $-74.17M | $-59.33M | $-99.33M | $-30.79M | $-99.99M | |
| FCF | Free Cash Flow |
|
$377.05M | $323.00M | $233.10M | $217.60M | $137.31M | $76.55M | $-101.27M | $-110.29M | $-39.93M | $-48.75M | $-30.15M | $-36.27M | $-1.43M | $49.62M | $-53.14M | $-75.49M | $-59.95M | $-102.44M | $-38.03M | $-153.14M | |
| FCFS | Free Cash Flow Per Share |
|
$3.70 | $3.37 | $2.46 | $2.34 | $1.50 | $0.85 | $-1.15 | $-1.27 | $-0.47 | $-0.65 | $-0.45 | $-0.55 | $-0.03 | $0.94 | $-1.36 | $-1.96 | $-1.58 | $-2.72 | $-1.03 | $-4.23 |
